SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/6E82EAF7176ECCB9261EE278CE598FAC859D6A777B0C959E06C5008668F2F6C64D71679F7B851D024157A0AE7A0AC04A>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/6E82EAF7176ECCB9261EE278CE598FAC859D6A777B0C959E06C5008668F2F6C64D71679F7B851D024157A0AE7A0AC04A
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/6E82EAF7176ECCB9261EE278CE598FAC859D6A777B0C959E06C5008668F2F6C64D71679F7B851D024157A0AE7A0AC04A
http://www.w3.org/2000/01/rdf-schema#comment
"The results from this large cohort of European patients treated with ustekinumab in daily clinical practice confirm the role of HLA-C*06 as a potential predictor of response to ustekinumab."
xsd:string
http://purl.uniprot.org/uniprot/#_D91553D06E2617BE78BD734F3D1F27408C3240EB75E979DB8DC8D36033E31C6E1ED36357017E697FDEF1BDAF1C2CBDCF
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/6E82EAF7176ECCB9261EE278CE598FAC859D6A777B0C959E06C5008668F2F6C64D71679F7B851D024157A0AE7A0AC04A
http://purl.uniprot.org/uniprot/M9P8K5
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/6E82EAF7176ECCB9261EE278CE598FAC859D6A777B0C959E06C5008668F2F6C64D71679F7B851D024157A0AE7A0AC04A
http://purl.uniprot.org/uniprot/#_M9P8K5-mappedCitation-28207934
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/6E82EAF7176ECCB9261EE278CE598FAC859D6A777B0C959E06C5008668F2F6C64D71679F7B851D024157A0AE7A0AC04A